97 related articles for article (PubMed ID: 20034901)
1. [Clinical significance of tumor interstitial T lymphocyte subset activity in non-small-cell lung cancer].
Xue L; Chen J; Peng JZ; Chen BS; Hua P; Yang YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2456-8. PubMed ID: 20034901
[TBL] [Abstract][Full Text] [Related]
2. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.
Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT
Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040
[TBL] [Abstract][Full Text] [Related]
3. Can the condition of the cell microenvironment of mediastinal lymph nodes help predict the risk of metastases in non-small cell lung cancer?
Zieliński P; Dyszkiewicz W; Piwkowski CT; Dworacki G; Gasiorowski L
Cancer Epidemiol; 2009 Nov; 33(5):387-90. PubMed ID: 19931500
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].
Su YJ; Ren K; Li H; Ren XB; Wang CL
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):922-6. PubMed ID: 18478932
[TBL] [Abstract][Full Text] [Related]
5. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC).
Erfani N; Mehrabadi SM; Ghayumi MA; Haghshenas MR; Mojtahedi Z; Ghaderi A; Amani D
Lung Cancer; 2012 Aug; 77(2):306-11. PubMed ID: 22608141
[TBL] [Abstract][Full Text] [Related]
6. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
Esendagli G; Bruderek K; Goldmann T; Busche A; Branscheid D; Vollmer E; Brandau S
Lung Cancer; 2008 Jan; 59(1):32-40. PubMed ID: 17825949
[TBL] [Abstract][Full Text] [Related]
7. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
8. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
9. Peripheral leukocytes with HLA-DR+/CD8- phenotype are associated with prognosis in patients with lung cancer.
Nakamura H; Saji H; Aute I; Kawasaki N; Hosaka M; Ogata A; Saijo T; Kato H
Anticancer Res; 2003; 23(5b):4149-52. PubMed ID: 14666616
[TBL] [Abstract][Full Text] [Related]
10. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.
Petersen RP; Campa MJ; Sperlazza J; Conlon D; Joshi MB; Harpole DH; Patz EF
Cancer; 2006 Dec; 107(12):2866-72. PubMed ID: 17099880
[TBL] [Abstract][Full Text] [Related]
11. [Relationship of MAGE-A1 expression with Ki-67 and tumor-infiltrating lymphocyte response in non-small cell lung carcinoma].
Yue JQ; Diao LM; Li BY; Zou ZY; Xiao J; Chen DP; Fan LF; Guan J
Ai Zheng; 2004 Feb; 23(2):219-22. PubMed ID: 14960250
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte subpopulations anomalies in lung cancer patients and relationship to the stage of disease.
Mazzoccoli G; Balzanelli M; Giuliani A; De Cata A; La Viola M; Carella AM; Bianco G; Tarquini R
In Vivo; 1999; 13(3):205-9. PubMed ID: 10459492
[TBL] [Abstract][Full Text] [Related]
14. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
[TBL] [Abstract][Full Text] [Related]
15. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
[TBL] [Abstract][Full Text] [Related]
16. Immune activation status of CD8+ T cells infiltrating non-small cell lung cancer.
Trojan A; Urosevic M; Dummer R; Giger R; Weder W; Stahel RA
Lung Cancer; 2004 May; 44(2):143-7. PubMed ID: 15084378
[TBL] [Abstract][Full Text] [Related]
17. The Role of Circulating T Follicular Helper Cells and Regulatory Cells in Non-Small Cell Lung Cancer Patients.
Guo Z; Liang H; Xu Y; Liu L; Ren X; Zhang S; Wei S; Xu P
Scand J Immunol; 2017 Aug; 86(2):107-112. PubMed ID: 28513867
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory effect of T cell subsets on PWM-induced IgG synthesis by blood lymphocytes in lung cancer.
Górny MK; Jezewska E; Skrzypczak A; Słowik-Gabryelska A; Zeromski J
Arch Immunol Ther Exp (Warsz); 1991; 39(3):243-52. PubMed ID: 1839762
[TBL] [Abstract][Full Text] [Related]
20. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T
Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
